Meridia Brand Name Drug News

Meridia Brand Name Drug News From AOL News

Contrave Rejected: What Does the FDA Have Against Diet Pills?

Today the Food and Drug Administration declined to approve Contrave, a new prescription weight-loss drug that an FDA advisory panel had recommended for approval. The FDA ruling on Contrave told drugmaker Orexigen Therapeutics that the agency was concerned about long-term use and potential implications on heart health....

Abbott Withdraws Diet Pill Meridia in US, Canada

WASHINGTON (Oct. 8) -- Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure from health regulators who say the drug increases the risk of heart attack and stroke in patients with a history of heart disease. Companies have struggled for decades to...

FDA Reviewing Weight-Loss Drug Meridia: What You Need to Know

(Sept. 13) -- Meridia, a weight-loss pill that's been available to consumers for over a decade, might soon be pulled from the American market over concerns that the drug increases risk of heart attack and stroke. A panel of experts commissioned by the Food and Drug Administration will convene Wednesday to debate the...

FDA Panel Rejects Experimental Weight Loss Pill

GAITHERSBURG, MD. (July 15) -- A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug's side effects outweigh its ability to help patients lose weight. The Food and Drug Administration panel voted 10-6 against Vivus's Qnexa, citing...

Positive Qnexa Review Follows 5 Notable Diet Pill Disasters

(July 13) -- Qnexa, one of three anti-obesity drugs being reviewed by the Food and Drug Administration, effectively reduces body weight among obese patients. That's the bottom line from the FDA today, ahead of a final decision in October. But the agency remains wary of Qnexa's potential side effects: The drug has been...